BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9717120)

  • 1. Superovulation with a high gonadotropin dose for in vitro fertilization: is it effective?
    Lashen H; Ledger W; López Bernal A; Evans B; Barlow D
    J Assist Reprod Genet; 1998 Aug; 15(7):438-43. PubMed ID: 9717120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Repeated superovulation induction after failure in previous IVF-ET cycles with the ultra-long protocol: Analysis of outcomes of clinical pregnancy].
    Wang B; Kong N; Liu JY; Zhang NY; Zhu YC; Zhou JJ
    Zhonghua Nan Ke Xue; 2017 Dec; 23(12):1099-1102. PubMed ID: 29738181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.
    Bagratee JS; Lockwood G; López Bernal A; Barlow DH; Ledger WL
    J Assist Reprod Genet; 1998 Feb; 15(2):65-9. PubMed ID: 9513843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome.
    Hock DL; Louie H; Shelden RM; Ananth CV; Kemmann E
    J Assist Reprod Genet; 1998 Aug; 15(7):427-30. PubMed ID: 9717118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled ovarian hyperstimulation regimen involving intermittent gonadotropin administration with a "short" protocol of gonadotropin releasing hormone agonist for in vitro fertilization.
    Suganuma N; Tsukahara SI; Kitagawa T; Furuhashi M; Asada Y; Kondo I
    J Assist Reprod Genet; 1996 Jan; 13(1):43-8. PubMed ID: 8825166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basic ovarian status and follicular response to superovulation stimulation in an in vitro fertilization and embryo transfer program].
    Wei Z; Zhang L; Li M
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jan; 32(1):27-30. PubMed ID: 9596867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different regimens of human gonadotropins for superovulation of rhesus monkeys: ovulatory response and subsequent luteal function.
    Vandevoort CA; Baughman WL; Stouffer RL
    J In Vitro Fert Embryo Transf; 1989 Apr; 6(2):85-91. PubMed ID: 2498448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super high estradiol response to gonadotropin stimulation in patients undergoing in vitro fertilization.
    Diamond MP; Buchholz T; Boyers SP; Lavy G; Shapiro BS; DeCherney AH
    J In Vitro Fert Embryo Transf; 1989 Apr; 6(2):81-4. PubMed ID: 2498447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
    Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40-48 years.
    Avrech OM; Royburt M; Sabah G; Zukerman Z; Pinkas H; Amit S; Ovadia J; Fisch B
    J Assist Reprod Genet; 1996 May; 13(5):395-400. PubMed ID: 8739055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative impact of high doses of follicle-stimulating hormone during superovulation on the ovulatory follicle function in small ovarian reserve dairy heifers†.
    Karl KR; Jimenez-Krassel F; Gibbings E; Ireland JLH; Clark ZL; Tempelman RJ; Latham KE; Ireland JJ
    Biol Reprod; 2021 Mar; 104(3):695-705. PubMed ID: 33205153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superovulatory response following FSH, eCG-FSH and hMG and pregnancy rates following transfer of hatched blastocyst embryos with different diameter and shape in dromedary camel.
    Ararooti T; Niasari-Naslaji A; Asadi-Moghaddam B; Razavi K; Panahi F
    Theriogenology; 2018 Jan; 106():149-156. PubMed ID: 29059602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.